MedTrace Logo

Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation

NCT05587881 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-03-26

No results posted yet for this study

Summary

Aim of this study will evaluate the Impact of Covid-19 vaccine on Safety and Efficacy of Hematological Patients Received Allogeneic Hematopoietic Stem Cell Transplantation.

Conditions

Interventions

BIOLOGICAL

COVID-19 vaccine(donor)

Donor received COVID-19 vaccine before stem cells collection.

BIOLOGICAL

COVID-19 vaccine(patient)

Patient received COVID-19 vaccine before allo-HSCT.

Sponsors & Collaborators

  • The First Affiliated Hospital of Soochow University

    lead OTHER

Principal Investigators

  • Depei Wu, M.D · The First Affilated Hospital of Soochow University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-11-01
Completion
2023-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05587881 on ClinicalTrials.gov